SLITs suppress tumor growth in vivo by silencing Sdf1/Cxcr4 within breast epithelium.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 18829537.
- Also identified by DOI 10.1158/0008-5472.CAN-08-1357 and PMC identifier 3075571.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The genes encoding Slits and their Robo receptors are silenced in many types of cancer, including breast, suggesting a role for this signaling pathway in suppressing tumorigenesis. The molecular mechanism underlying these tumor-suppressive effects has not been delineated. Here, we show that loss of Slits, or their Robo1 receptor, in murine mammary gland or human breast carcinoma cells results in coordinate up-regulation of the Sdf1 and Cxcr4 signaling axis, specifically within mammary epithelium. This is accompanied by hyperplastic changes in cells and desmoplastic alterations in the surrounding stroma. A similar inverse correlation between Slit and Cxcr4 expression is identified in human breast tumor tissues. Furthermore, we show in a xenograft model that Slit overexpression down-regulates CXCR4 and dominantly suppresses tumor growth. These studies classify Slits as negative regulators of Sdf1 and Cxcr4 and identify a molecular signature in hyperplastic breast lesions that signifies inappropriate up-regulation of key prometastatic genes.
Medical subject headings
- Breast Neoplasms
- Carcinoma
- Chemokine CXCL12
- Gene Silencing
- Nerve Tissue Proteins
- Receptors, CXCR4